Orchid Pharma Ltd - 524372 - Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1010 Name of the Signatory :- L CHANDRASEKARDesignation :- Company Secretary and Compliance Officer Orchid Pharma Ltd - 524372 - Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
Updates on meeting of Committee of Creditors Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Amendment to Code of Practices and Procedures for fair disclosure of Unpublished Price Sensitive Information(UPSI) Orchid India invests $2.6 million in WedMeGood online wedding platform
The fund was an early investor in unicorns such as C-trip and Autohome, and has also invested in the Chinese online wedding platform Hunliji. Orchid Pharma Ltd - 524372 - Certificate Under Regulation 7(3)Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations,2015 For The Half Year Ended March 31,2019
Certificate under Regulation 7(3)of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015 for the half year ended March 31,2019 NCLT reads insolvency rules at Orchid Pharma's promoter group firm
The bank's dues, by July 2018, were Rs 215.7 crore Orchid Pharma Ltd - 524372 - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
Publication for Submission of Expression of Interest under Insolvency and Bankruptcy Code,2016 Orchid Pharma to soon issue invitation for new EoI from potential investors
The NCLT issued its order after Ingen failed to deposit Rs 1,000 cr for the creditors Orchid Pharma Ltd - 524372 - Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations,2015
Disclosure under Regulation 30 of the SEBI (LODR) Regulations,2015 Orchid Pharma Ltd - 524372 - OUTCOME OF MEETING- APPROVAL OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER/NINE MONTHS ENDED DECEMBER 31,2018
OUTCOME OF MEETING- APPROVAL OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER/NINE MONTHS ENDED DECEMBER 31,2018